abstract |
The invention relates generally to antibodies that bind CD7 1, activatable antibodies that nspecifically bind to CD7 1 and methods of making and using these anti-CD71 antibodies and nanti-CD71 activatable antibodies in a variety of therapeutic, dia-gnostic and prophylactic nindications. |